206 related articles for article (PubMed ID: 12960383)
1. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.
Pietra G; Romagnani C; Mazzarino P; Falco M; Millo E; Moretta A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10896-901. PubMed ID: 12960383
[TBL] [Abstract][Full Text] [Related]
2. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
3. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
[TBL] [Abstract][Full Text] [Related]
4. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
6. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
[TBL] [Abstract][Full Text] [Related]
7. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
8. Characterization of host immunity to cytomegalovirus pp150 (UL32).
La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ
Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996
[TBL] [Abstract][Full Text] [Related]
9. Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.
Villacres MC; Lacey SF; Auge C; Longmate J; Leedom JM; Diamond DJ
J Infect Dis; 2003 Sep; 188(6):908-18. PubMed ID: 12964124
[TBL] [Abstract][Full Text] [Related]
10. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
11. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
[TBL] [Abstract][Full Text] [Related]
12. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections.
Kim SK; Angevine M; Demick K; Ortiz L; Rudersdorf R; Watkins D; DeMars R
J Immunol; 1999 Jun; 162(11):6855-66. PubMed ID: 10352308
[TBL] [Abstract][Full Text] [Related]
13. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
14. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
[TBL] [Abstract][Full Text] [Related]
15. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
16. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment.
Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
Eur J Immunol; 2003 Oct; 33(10):2910-6. PubMed ID: 14515275
[TBL] [Abstract][Full Text] [Related]
17. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.
Allard M; Tonnerre P; Nedellec S; Oger R; Morice A; Guilloux Y; Houssaint E; Charreau B; Gervois N
PLoS One; 2012; 7(11):e50951. PubMed ID: 23226431
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
[TBL] [Abstract][Full Text] [Related]
19. Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice.
Takeshita T; Fukui Y; Yamamoto K; Yamane K; Inamitsu T; Kamikawaji N; Sasazuki T
Jpn J Hum Genet; 1997 Mar; 42(1):225-32. PubMed ID: 9184003
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
